| Literature DB >> 31694556 |
Maria Sakalaki1,2, Salim Barywani3,4, Annika Rosengren3,4, Lena Björck3, Michael Fu3,4.
Abstract
BACKGROUND: Secondary prevention after an acute myocardial infarction (AMI) reduces morbidity and mortality, but suboptimal secondary prevention of cardiovascular disease is common. Therefore, the present study aimed to identify potential underlying factors for suboptimal secondary prevention 2 years after an AMI event.Entities:
Keywords: Cardiovascular disease; Diabetes; Myocardial infarction; Secondary prevention
Mesh:
Substances:
Year: 2019 PMID: 31694556 PMCID: PMC6833166 DOI: 10.1186/s12872-019-1238-5
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Baseline characteristics at the time of the index AMI and corresponding values at 2 years of follow-up
| At baseline | At 2 years of follow-up | ||
|---|---|---|---|
| Age | 63.3 ± 9.7 | 65.5 ± 9,8 | |
| Smoker | 45 (22.5) | 25 (12.5) | < 0.001 |
| Overweight* | 129 (65.5) | 144 (72) | < 0.001 |
| Systolic BP (mmHg) | 146.8 ± 23.4 | 137.5 ± 18.0 | < 0.001 |
| Diastolic BP (mmHg) | 91.3 ± 15.0 | 79.6 ± 10.3 | < 0.001 |
| Heart rate (beats/min) | 75.6 ± 18.8 | 62.1 ± 10.6 | < 0.001 |
| Hypertension | 102 (51.0) | 123 (63.4) ( | 0.157 |
| Hyperlipidemia | 53 (26.5) | 115 (63.5) ( | 0.209 |
| Diabetes type1/type2 | 26 (13.0) | 43 (21.8) ( | 0.259 |
| Heart failure | 6 (3.0) | 14 (7) | < 0.001 |
| Atrial fibrillation | 8 (4.0) | 29 (14.8) ( | 0.439 |
| Stroke or TIA | 12 (6.0) | 14 (7.2) ( | 0.319 |
| Renal failure | 4 (2.0) | 9 (4.5) | < 0.001 |
| Aspirin | 199 (99.5) | 183 (91.5) ( | 0.774 |
| Betablockers | 187 (93.5) | 166 (84.3) ( | 0.452 |
| Statins | 193 (96.5) | 177 (89.4) ( | 0.628 |
| ACE-inhibitors or ARB | 177 (88.5) | 153 (76.5) | 0.463 |
*BMI ≥ 25 kg/m2. BP Blood pressure, IHD Ischemic heart disease, TIA Transient ischemic attack, ACE Angiotensin converting enzyme, ARB Angiotensin receptor blockers. Data are expressed as mean ± SD or n (%)
#Actual number of patients at 2 years of follow-up
Achieved secondary prevention goals at the 2-year follow-up after AMI compared with corresponding baseline values
| Achieved secondary prevention goals | At baseline | At 2 years of follow-up | |
|---|---|---|---|
| Non-smoking, | 154 (77.4) ( | 175 (87,5) | 0.398 |
| Regularly activity*, | No data | 91 (45,5) | No data |
| BP < 140/90 mmHg, | 63 (31.5) | 106 (53,0) | 0.466 |
| HbA1c < 48 mmol/mol, | No data | 177 (88,5) | No data |
| LDL < 1,8 mmol, | 9 (5) ( | 37 (18,5) | 0.096 |
| BMI < 25 kg/m2, | 67 (33.5) | 56 (28) | 0.961 |
*Regular physical activity that causes sweating at least two times per week. BP Blood pressure, LDL Low-density lipoprotein, BMI Body mass index
#Actual number of patients at baseline
Fig. 1Percentage of achieved goals of guideline recommended secondary prevention 2 years post AMI
Patient characteristics at the 2-year follow-up after an acute myocardial infarction: a comparison between patients who achieved > 4 and those who achieved < 4 secondary preventive goals
| < 4 achieved goals | ≥4achieved goals | ||
|---|---|---|---|
| Age, mean ± SD | 66.1 ± 9.0 | 65.2 ± 10.1 | 0.615 |
| ≤ 65 years | 31 (50.8) | 64 (46.0) | 0.541 |
| Demographic variable | |||
| Born in Sweden | 52 (85.2) | 106 (76.3) | 0.120 |
| Living alone | 28 (45.9) | 31 (22.3) | 0.001 |
| Higher education | 13 (21.3) | 34 (24.5) | 0.412 |
| Currently working | 20 (32.8) | 52 (37.4) | 0.632 |
| Clinical status | |||
| Systolic BP (mmHg) | 143.3 ± 16.3 | 135.2 ± 18.1 | 0.226 |
| Diastolic BP (mmHg) | 82.4 ± 11.1 | 78.7 ± 9.7 | 0.855 |
| Heart rate (beats/min) | 66.7 ± 11.6 | 60.1 ± 9.5 | 0.277 |
| Cardiovascular diseases | |||
| Heart failurea | 4 (6.6) | 10 (7.2) | 1.000 |
| Atrial fibrillationa | 4 (6.6) | 9 (6.5) | 1.000 |
| Stroke or TIAa | 1 (1.6) | 8 (5.8) | 0.518 |
| Kidney failurea | 3 (4.9) | 6 (4.3) | 0.587 |
BP Blood pressure, TIA Transient ischemic attack. Data are expressed as mean ± SD or n (%). aSelf-specified answers to questions in the SEPAT questionnaire
Independent predictors of achievement of different secondary preventive goals after AMI assessed by; multivariable logistic regression models
| Odds ratio (95% CI) | ||
|---|---|---|
| Achieved non-smoking | ||
| Sex, male | 0.17 (0.02–1.34) | 0.093 |
| Age | 0.24 (0.07–0.74) | 0.013 |
| Unemployed | 0.23 (0.06–0.82) | 0.023 |
| Achieved LDL < 1,8 mmol/L | ||
| Overweight | 0.52 (0.24–1.12) | 0.096 |
| Native-born | 0.28 (0.12–0.63) | 0.002 |
| Achieved HbA1c < 48 mmol/mol | ||
| Sex, male | 0.46 (0.18–1.18) | 0.106 |
| BMI | 0.91 (0.82–1.02) | 0.095 |
| Achieved regular physical activity | ||
| Sex, male | 1.95 (0.93–4.09) | 0.078 |
| Living alone | 1.94 (1.02–3.69) | 0.044 |
| Achieved BMI < 25 kg/m2 | ||
| Living alone | 0.45 (0.20–1.00) | 0.050 |
| Diabetes type1/type2 | 0.21 (0.04–0.98) | 0.046 |
| Walking difficulties | 0.23 (0.07–0.71) | 0.011 |
| Achieved blood pressure < 140/90 mmHg | ||
| Diabetes type1/type2 | 1.86 (0.61–5.62) | 0.271 |
| Heart failure after admission, ≤ 45% | 2.77 (1.05–7.31) | 0.040 |
| Left ventricular hypertrofi | 1.40 (0.57–3.48) | 0.466 |
| Age > 65 years | 1.49 (0.70–3.20) | 0.301 |
| Sex, male | 0.36 (0.13–0.97) | 0.043 |
LDL Low-density lipoprotein, BMI Body mass index. Data are expressed as Odds ratio (95% CI)